Chemical Structure : KT-531
Catalog No.: PC-72739Not For Human Use, Lab Use Only.
KT-531 (KT531) is a potent, selective HDAC6 inhibitor with IC50 of 8.5 nM, displays 39-fold selectivity.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
KT-531 (KT531) is a potent, selective HDAC6 inhibitor with IC50 of 8.5 nM, displays 39-fold selectivity over other HDAC isoforms.
KT-531 demonstrated biological potency in multiple hematological cancer cell models (acute myeloid leukemia (AML), PTCL, and T-cell acute lymphoblastic leukemia (T-ALL)) and limited cytotoxicity in nonmalignant cell types as well as no observable toxicity in vivo (CD-1 mice).
KT-531 exhibited strong potency (IC50=0.42 μM) in the T-ALL/T-PLL-like cell line SUP-T11, demonstrated higher cytotoxicity than Nexturastat in MV4-11 cancer cells (IC50=0.42 uM versus 1.68 uM).
KT-531 showed high synergy with chemotherapeutic agents idasanutlin, bendamustine, and venetoclax in T-PLL patient samples.
KT-531 is the first HDAC6 inhibitor to show efficacy in T-PLL patient samples.
M.Wt | 418.363 | |
Formula | C17H14F4N2O4S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Krimo Toutah, et al. J Med Chem. 2021 Jun 24;64(12):8486-8509.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright